Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
JP Fermand, F Bridoux, A Dispenzieri… - Blood, The Journal …, 2018 - ashpublications.org
Monoclonal gammopathy is a common condition, particularly in the elderly. It can indicate
symptomatic multiple myeloma or another overt malignant lymphoid disorder requiring …
symptomatic multiple myeloma or another overt malignant lymphoid disorder requiring …
Cryoglobulinaemia
D Roccatello, D Saadoun, M Ramos-Casals… - Nature Reviews …, 2018 - nature.com
Cryoglobulinaemia refers to the serum presence of cryoglobulins, which are defined as
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …
immunoglobulins that precipitate at temperatures< 37° C. Type I cryoglobulinaemia consists …
[HTML][HTML] International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement
Hepatitis C virus (HCV) is both hepatotrophic and lymphotropic virus that causes liver as
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …
well extrahepatic manifestations including cryoglobulinemic vasculitis, the most frequent and …
Hepatitis C virus infection and chronic kidney disease: time for reappraisal
P Cacoub, AC Desbois, C Isnard-Bagnis… - Journal of …, 2016 - Elsevier
Hepatitis C virus (HCV) infection is associated with tremendous morbidity and mortality due
to liver complications. HCV infection is also associated with many extrahepatic …
to liver complications. HCV infection is also associated with many extrahepatic …
[PDF][PDF] KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
KDIGO Hepatitis C Work Group - Kidney International …, 2018 - discovery.ucl.ac.uk
The development and publication of this guideline were supported by KDIGO. The opinions
or views expressed in this professional education supplement are those of the authors and …
or views expressed in this professional education supplement are those of the authors and …
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection
The hepatitis C virus (HCV), a linear, single-stranded RNA virus identified in 1989, is a
hepatotropic virus that causes liver cirrhosis and hepatocellular cancer and is a global …
hepatotropic virus that causes liver cirrhosis and hepatocellular cancer and is a global …
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
Cryoglobulinemic vasculitis (CV) or mixed cryoglobulinemic syndrome (MCS) is a systemic
small-vessel vasculitis characterized by the proliferation of B-cell clones producing …
small-vessel vasculitis characterized by the proliferation of B-cell clones producing …
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome
M Galli, G Monti, P Marson, P Scaini… - Autoimmunity …, 2019 - Elsevier
Objective Some of the manifestations of mixed cryoglobulinemia syndrome (MCS) can be
severe or life-threatening, and should be rapidly contained but, as the therapeutic …
severe or life-threatening, and should be rapidly contained but, as the therapeutic …
KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
This article is published as part of a supplement supported by Kidney Disease: Improving
Global Outcomes (KDIGO). The development and publication of this guideline were …
Global Outcomes (KDIGO). The development and publication of this guideline were …
The impact of rituximab infusion protocol on the long‐term outcome in anti‐MuSK myasthenia gravis
E Cortés‐Vicente, R Rojas‐Garcia… - Annals of clinical …, 2018 - Wiley Online Library
Objective To evaluate whether the clinical benefit and relapse rates in anti‐muscle‐specific
kinase (Mu SK) myasthenia gravis (MG) differ depending on the protocol of rituximab …
kinase (Mu SK) myasthenia gravis (MG) differ depending on the protocol of rituximab …